U.S. Food and Drug Administration at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

U.S. Food and Drug Administration brings 2 presentations to ObesityWeek 2026 in National Harbor. Its program reviews the year in obesity approvals and regulatory updates.

OrganizationObesityWeek 2026 Attendance
Government agencies
Federal agency that reviews and approves drugs and devices, including obesity medications.
Session
Mon Nov 16
3:30pm–4:30pm
The Year in Obesity Approvals and Regulatory Updates
FDA staff review the past year's obesity drug approvals, label changes and safety notices, and preview regulatory and scientific issues ahead.
Woodrow Wilson, Ballroom Level
with Oregon Health & Science University
Population health and epidemiologyClinical obesity care and professional practiceObesity pharmacotherapy and drug developmentPediatric and adolescent obesity
Talk
Mon Nov 16
3:30pm–4:10pm
The Year in Obesity Approvals and Regulatory Updates
Woodrow Wilson, Ballroom Level
Population health and epidemiologyClinical obesity care and professional practiceObesity pharmacotherapy and drug developmentPediatric and adolescent obesity

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at U.S. Food and Drug Administration

Tell us what you sell and we’ll find the people at U.S. Food and Drug Administration most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction